Last updated: May 27, 2026

GHK-Cu Peptide: Complete Research Guide 2026

Introduction

GHK-Cu peptide — the copper complex of glycyl-L-histidyl-L-lysine — has occupied a quiet but persistent place in regenerative biochemistry since Loren Pickart’s 1973 isolation work. This reference page consolidates the mechanistic, analytical, and laboratory-handling literature on GHK-Cu for research professionals working with the compound in vitro or in pre-clinical models. All material is presented for research use only (RUO).

Quick Facts: GHK-Cu Peptide

Definition: A naturally occurring copper-binding tripeptide composed of glycine, histidine, and lysine, complexed with a copper(II) ion.
Chemical identity: Gly-His-Lys-Cu(II); CAS 89030-95-5 (peptide), 49557-75-7 (complex); molecular formula C₁₄H₂₄CuN₆O₄.
Mechanism: Acts as a signal peptide that modulates fibroblast activity, collagen and glycosaminoglycan synthesis, antioxidant signaling, and copper bioavailability [1][2].
Primary research applications: In-vitro and pre-clinical models of skin regeneration, wound repair, hair-follicle biology, and tissue remodeling [3].
Regulatory status: Sold strictly for research use only in the U.S.; not approved for human therapeutic or veterinary use.

What Is GHK-Cu?

GHK-Cu is the copper-bound form of the human tripeptide glycyl-L-histidyl-L-lysine, originally isolated by Pickart from human plasma albumin in 1973 [1]. The free peptide chelates a Cu²⁺ ion with high affinity, generating a deep cobalt-blue complex that is the workhorse molecule of modern copper-peptide research. Plasma concentrations of GHK in humans are reported at roughly 200 ng/mL in young adults and decline to approximately 80 ng/mL by age sixty [2].

The GHK Tripeptide and Its Copper Complex

The GHK sequence — glycine, histidine, lysine — is small enough to qualify as a “signal peptide,” meaning it interacts with cell-surface and intracellular targets to alter transcriptional programs rather than acting as a structural building block. When GHK encounters Cu²⁺ under physiological conditions, the histidine imidazole nitrogen and the N-terminal amine coordinate the metal, with lysine contributing to the binding pocket. The resulting Gly-His-Lys-Cu(II) complex shifts the peptide’s behavior from a passive ligand to an active modulator of intracellular copper trafficking [2].

Definition Box – Signal Peptide: A short peptide sequence that triggers downstream cellular responses (gene expression, enzyme activation, cytokine release) by interacting with receptors or transport proteins rather than by being incorporated into larger structures.

Chemical Identity and Structure (Glycyl-L-Histidyl-L-Lysine + Cu²⁺)

The free tripeptide GHK has the formula C₁₄H₂₄N₆O₄ and a molecular weight of approximately 340.4 g/mol. When complexed with copper, the canonical Gly-His-Lys-Cu(II) species carries a molecular weight near 403–404 g/mol; the acetate salt commonly seen on research COAs (Gly-His-Lys-Cu(II) acetate) sits at roughly 462 g/mol. Reference standards typically appear as a fine lyophilized powder with a characteristic blue tint when adequate copper is bound — visual confirmation, though not a substitute for HPLC and mass spectrometry.

GHK-Cu vs Copper Tripeptide-1 vs Cu-GHK — Terminology Clarified

Three names dominate the literature and confuse buyers:

GHK-Cu — the standard scientific shorthand used in peer-reviewed papers.
Copper tripeptide-1 — the INCI (International Nomenclature of Cosmetic Ingredients) designation, used on cosmetic labels.
Cu-GHK — a less common ordering seen in older biochemistry literature.

All three refer to the same Gly-His-Lys-Cu(II) coordination compound. Research-grade GHK-Cu and cosmetic-grade copper tripeptide-1 share a chemical identity, but the purity specifications, impurity profiles, and analytical documentation differ substantially — a distinction examined later in this guide.

Discovery and Research History (Pickart, 1973–Present)

Pickart’s foundational observation was that plasma from young donors caused liver cells from older donors to behave more like young tissue. The active fraction was traced to a glycyl-L-histidyl-L-lysine sequence [1]. A 1980 paper in *Nature* proposed that GHK functions by facilitating copper uptake into cells [4]. Subsequent work through the 1980s and 1990s expanded the compound’s reported activities into wound healing, fibroblast restoration, and tissue remodeling. The 2010s introduced gene-expression analysis: data generated through the Broad Institute’s Connectivity Map indicated that GHK exposure modulated expression of 4,192 of the 13,424 human genes assayed, with approximately equal up- and down-regulation across stress-response, inflammation, and tissue-repair pathways [2].

Key Takeaway: GHK-Cu is the copper(II) complex of a naturally occurring human tripeptide first isolated in 1973. Its primary research interest stems from its activity as a signal peptide that modulates fibroblast behavior, copper trafficking, and gene expression across regenerative pathways.

Mechanism of Action: How GHK-Cu Works at the Cellular Level

Investigators have characterized GHK-Cu’s activity across several overlapping mechanisms. None operate in isolation; the compound’s apparent biological effect at any given concentration reflects the sum of these signals.

Signal Peptide Activity and Fibroblast Stimulation

In-vitro studies on cultured dermal fibroblasts have consistently reported that GHK-Cu exposure at nanomolar to low-micromolar concentrations restores proliferative capacity in senescent or irradiated cells [2][3]. The peptide does not appear to bind a single dedicated receptor; instead, the leading model holds that GHK-Cu delivers copper to intracellular pools and concurrently engages multiple signaling intermediates linked to fibroblast activation.

Collagen, Elastin, and Glycosaminoglycan Pathways

Pre-clinical data points to increased synthesis of collagen, elastin, and glycosaminoglycans following GHK-Cu exposure in fibroblast cultures [2][3]. The extracellular matrix proteins decorin, perlecan, and biglycan have all been reported as upregulated targets. These findings have repeatedly framed GHK-Cu’s research interest in dermatological and connective-tissue models.

Definition Box — Glycosaminoglycans (GAGs): Long, unbranched polysaccharides (including hyaluronic acid, chondroitin sulfate, and dermatan sulfate) that hydrate the extracellular matrix and support tissue elasticity and structural cohesion.

Copper Transport and Bioavailability

Copper is an essential cofactor for lysyl oxidase, superoxide dismutase, and several other enzymes critical to connective-tissue assembly and redox balance. Investigators have proposed that GHK-Cu’s central function is to deliver copper to fibroblasts in a controlled, non-toxic form — buffering against the redox damage that free Cu²⁺ would otherwise cause [4]. This “controlled delivery” model is one of the more durable explanations in the literature.

Antioxidant and Anti-Inflammatory Signaling

GHK has been reported to quench reactive carbonyl species, including 4-hydroxy-trans-2-nonenal, with kinetics comparable to carnosine [5]. Pre-clinical work also shows GHK-Cu reducing markers of oxidative stress and inflammatory cytokines in tissue-injury models. The combination of redox buffering and inflammatory damping is a recurring theme across the compound’s reported applications.

Gene Expression Modulation

The Broad Institute Connectivity Map analysis is the single most-cited modern data point on GHK. Of the 13,424 human genes assayed, GHK exposure produced ≥50% expression changes in 4,192 of them [2]. Subsequent work by Pickart and Margolina identified clusters of affected genes spanning DNA repair, antioxidant defense, ubiquitin–proteasome activity, anti-inflammatory signaling, and tissue remodeling [2]. Investigators have described this pattern as a “broad reset” of pathways associated with cellular aging — language that, while evocative, remains pre-clinical and has not been translated into validated human therapeutic claims.

Key Takeaway: GHK-Cu acts through multiple overlapping mechanisms — fibroblast activation, controlled copper delivery, antioxidant signaling, and broad gene-expression modulation. No single receptor accounts for its activity; the literature treats it as a multi-pathway signal peptide.

Primary Research Applications of GHK-Cu

GHK-Cu’s peer-reviewed literature concentrates in six application areas. Each one is briefly summarized below as it appears in published in-vitro and pre-clinical work — not as a therapeutic claim.

Skin Regeneration and Anti-Aging Research

The bulk of GHK-Cu literature sits here. Investigators have reported reductions in wrinkle depth, improvements in skin density, and increased dermal fibroblast activity in pre-clinical and limited human-skin studies [2][6]. Mechanistic underpinnings center on collagen/elastin/GAG upregulation and antioxidant signaling described above.

Wound Healing and Tissue Repair Studies

Multiple animal models — rodent skin wound, diabetic ulcer analogs, and surgical wound healing — have reported accelerated closure and improved tensile strength of healed tissue following topical GHK-Cu application [3][7]. Angiogenic signaling and macrophage recruitment have been proposed as contributing mechanisms.

Hair Follicle and Hair Growth Research

GHK-Cu’s interaction with dermal papilla cells has drawn attention in androgenic-alopecia models. Pre-clinical reports describe increased follicle size, prolonged anagen phase, and improved scalp vascularization in animal studies and ex-vivo follicle cultures [8]. Human evidence remains limited and primarily cosmetic.

Post-Procedure Skin Recovery Research (microneedling, laser, peel models)

In dermatology research models simulating post-procedure conditions (controlled barrier disruption, fractional laser injury), GHK-Cu has been reported to shorten erythema duration and accelerate barrier-protein recovery [6].

Nerve and Vascular Regrowth Research

A smaller but mechanistically interesting cluster of studies examines GHK-Cu in nerve-regeneration and angiogenesis contexts. Pre-clinical data suggests upregulation of nerve growth factor and vascular endothelial growth factor in injury models [9]. These pathways remain early-stage research targets.

Skin Barrier Repair Models

In barrier-disruption models, GHK-Cu has been reported to support recovery of stratum-corneum lipid composition and tight-junction protein expression [6]. This work overlaps significantly with the post-procedure recovery literature.

Key Takeaway: Six application areas dominate the GHK-Cu research literature: skin regeneration, wound healing, hair follicle biology, post-procedure recovery, nerve and vascular regrowth, and barrier repair. All cited findings remain pre-clinical or limited cosmetic-research data.

GHK-Cu Compared to Other Research Peptides and Actives

Feature	GHK-Cu	BPC-157
Sequence length	3 amino acids + Cu²⁺	15 amino acids
Origin	Plasma-derived tripeptide	Synthetic, derived from gastric protein BPC
Primary research focus	Skin, fibroblast, collagen, hair	GI mucosa, tendon, ligament, vascular
Reported mechanism	Signal peptide, copper delivery	Angiogenic, growth-factor modulation
Stability profile	Stable lyophilized; copper coordination matters	Stable lyophilized; sequence-dependent

GHK-Cu vs Retinol (Mechanism Comparison)

Retinol acts via nuclear retinoic acid receptors and modifies transcription of keratinocyte differentiation and dermal remodeling genes. GHK-Cu operates through a different axis — fibroblast activation, copper trafficking, and broad gene modulation — without engaging the retinoid receptor family. The two are not interchangeable in research design and are often examined separately.

GHK-Cu vs Vitamin C (Collagen Pathway)

L-ascorbic acid is a required cofactor for prolyl and lysyl hydroxylases that stabilize the collagen triple helix. GHK-Cu acts upstream of collagen synthesis by stimulating fibroblast activity and matrix gene expression. The two interact in different parts of the collagen pathway — Vitamin C as an enzymatic cofactor, GHK-Cu as a signaling input.

Research-Grade GHK-Cu vs Cosmetic Copper Peptide Serums

Specification	Research-Grade GHK-Cu	Cosmetic Copper Peptide Serum
Purity standard	≥99% by HPLC	Typically not disclosed; formulation-grade
Impurity documentation	COA with HPLC and MS data	Generally none
Concentration	Defined (mg/vial, lyophilized)	Variable %; often 0.1–2%
Identity verification	LC-MS confirmation	Not standard
Carrier matrix	None (powder)	Aqueous serum with excipients
Intended use	In-vitro research, pre-clinical models	Topical cosmetic application

Injectable vs Topical Forms in Research Literature

The published literature is heavily weighted toward topical and in-vitro application. Sub-cutaneous and intra-dermal injection has been used in animal-model wound studies [3][7]. GHK-Cu is not approved for human injectable use; all such literature is pre-clinical.

Key Takeaway: GHK-Cu, BPC-157, retinol, and Vitamin C occupy different points in the regenerative and dermatological-research landscape. Research-grade GHK-Cu is distinguished from cosmetic copper peptide serums primarily by documentation, purity verification, and absence of formulation excipients.

Laboratory Handling: Reconstitution, Solubility, and Stability

This section describes laboratory handling of GHK-Cu as a reference standard. It is not guidance for human administration.

Solubility Profile and Recommended Solvents

GHK-Cu is water-soluble. The lyophilized powder typically dissolves readily in sterile water, bacteriostatic water (0.9% benzyl alcohol), or buffered saline at room temperature with gentle agitation. Investigators working in cell-culture protocols frequently prepare stock solutions in sterile water at 1–10 mg/mL and then dilute into culture medium to working concentrations.

Reconstitution with Bacteriostatic Water (Research Protocols)

A typical research reconstitution workflow involves:

Allowing the sealed vial to equilibrate to room temperature.
Drawing the calculated volume of bacteriostatic or sterile water with a sterile syringe.
Injecting the solvent slowly down the vial wall — not directly onto the lyophilized cake.
Gently swirling (not vortexing) until the powder fully dissolves and the solution displays its characteristic cobalt-blue color.
Aliquoting into sterile, low-bind tubes for storage and use.

For broader peptide reconstitution context, see [our reconstitution reference guide].

Stability in Buffered Solutions

GHK-Cu is generally stable in neutral and mildly acidic aqueous buffers. Strongly basic conditions, high temperatures, and prolonged exposure to light can compromise the copper coordination and degrade the peptide. Buffered solutions held at 2–8 °C are typically used within 14–28 days for sensitive in-vitro work; extended storage is moved to −20 °C aliquots [10].

Storage Conditions and Shelf Life

Lyophilized GHK-Cu stored at −20 °C in sealed vials with desiccant retains stability for 24+ months under typical research-storage conditions. Reconstituted solutions should be aliquoted to minimize freeze-thaw cycles. See [our reconstituted-peptide stability guide]

Common Concentrations Used in Published Research

Published in-vitro work commonly uses GHK-Cu at concentrations between 10 nM and 10 μM in fibroblast culture, with 1 μM representing a frequently reported working concentration [2][3]. Animal-model topical studies have used solutions ranging from 0.05% to 0.2% (w/v). These figures describe the published literature, not recommended human applications.

Key Takeaway: GHK-Cu is water-soluble, generally stable in neutral aqueous buffers, and stored long-term as a lyophilized powder at −20 °C. Reconstituted working solutions are typically held at 2–8 °C and used within weeks, with aliquoting to minimize freeze-thaw degradation.

Purity, Testing, and Quality Verification

HPLC and Mass Spectrometry Analysis

Reversed-phase HPLC quantifies peptide purity by separating the main peak from synthesis-derived impurities. Research-grade GHK-Cu typically reports ≥99% purity by this method. LC-MS confirms identity by measuring the molecular mass and comparing it to the theoretical value (≈403–404 g/mol for the parent complex, ≈462 g/mol for the acetate salt). Both analyses appear on a complete certificate of analysis.

How to Read a Certificate of Analysis (COA)

A complete GHK-Cu COA documents:

Product identity: Name, CAS number, batch/lot number, manufacture date.
HPLC purity: Numeric percentage and accompanying chromatogram.
Identity confirmation: LC-MS molecular weight matching the theoretical value.
Appearance: Visual description of the lyophilized cake.
Solubility / reconstitution notes: Recommended solvents.
Storage recommendations: Temperature and container specifications.
Impurity profile: Identified secondary peaks and their relative abundance.

For a worked walkthrough, see our [sample COA documentation].

Impurity Markers to Check

Common synthesis-related impurities in tripeptide products include truncated sequences (Gly-His or His-Lys fragments), residual coupling reagents, and counterion residues from purification. Free, uncomplexed GHK and excess copper salts can also appear; the COA should report their relative abundance.

Why 99% Purity Matters in Research Outcomes

Reproducibility in cell-culture and pre-clinical models depends on consistent reagent quality. Sub-99% material introduces unknown variables — uncharacterized impurity peaks may have their own biological activity or confound assay readouts. For sensitive applications such as gene-expression profiling or receptor-binding work, the difference between 95% and 99% purity is operationally significant.

Key Takeaway: Research-grade GHK-Cu is verified by reversed-phase HPLC (purity) and LC-MS (identity), with full documentation provided on a certificate of analysis. The ≥99% purity threshold supports reproducibility in sensitive in-vitro and pre-clinical work.

Regulatory and Legal Status

Research-Use-Only (RUO) Classification

GHK-Cu sold by 99 Purity Peptides and comparable research-grade suppliers is supplied for research use only. RUO classification means the material is intended for in-vitro research, assay development, and pre-clinical laboratory work — not for diagnostic, therapeutic, or human-administration purposes.

FDA Position on Research Peptides

GHK-Cu is not an FDA-approved drug. The Food and Drug Administration regulates therapeutic peptides separately from research reagents; research-grade peptides are not evaluated for clinical efficacy or safety in human use [11]. Researchers using GHK-Cu in any pre-clinical study should confirm institutional and federal compliance independently.

Research-Grade vs Cosmetic-Grade Regulatory Differences

Cosmetic copper peptide products containing copper tripeptide-1 are regulated as cosmetics by the FDA when sold for topical personal-care use. They are subject to cosmetic labeling and safety rules, not pharmaceutical standards. Research-grade GHK-Cu sits outside the cosmetic regulatory category entirely; it is supplied as a chemical reagent for laboratory use.

Sourcing GHK-Cu for Academic and Private US Labs

Academic, government, and private research laboratories in the United States typically source research-grade peptides from suppliers that provide a complete COA, RUO labeling, and verifiable HPLC/MS documentation. Verification of supplier analytical practices is standard institutional procurement practice. For broader context on research peptide sourcing in the US, see our [research peptides overview guide](https://99puritypeptides.com/what-are-research-peptides-complete-laboratory-guide-2026/).

Key Takeaway: GHK-Cu is sold strictly for research use only in the U.S. and is not approved for human therapeutic use. Research-grade material differs in regulatory category, documentation, and quality control from cosmetic copper peptide products.

Reported Limitations and Considerations in GHK-Cu Research

Gaps in the Current Evidence Base

Despite a substantial pre-clinical record, GHK-Cu lacks large-scale human clinical trial data for most reported applications. Much of the evidence rests on in-vitro fibroblast work, rodent wound-healing models, and small cosmetic-research panels. Reviewers have repeatedly noted the need for randomized controlled trials before any therapeutic claim can be supported [12].

Pre-clinical vs Clinical Translation Challenges

Concentrations that produce robust in-vitro fibroblast responses may not translate predictably to in-vivo or human contexts. Skin penetration, plasma binding, and copper-pool dynamics complicate dose extrapolation. This is a general challenge for signal peptides and is not unique to GHK-Cu.

Handling and Stability Risks

Improper handling — exposure to light, heat, repeated freeze-thaw cycles, or strongly alkaline conditions — can degrade the peptide or disrupt copper coordination, producing experimental variability that is sometimes mistaken for biological inconsistency.

Why Research-Grade Sourcing Matters

Variability in supplier purity is a recurring issue across the research-peptide market. Material that tests below specification, lacks identity confirmation, or carries undocumented impurities undermines reproducibility. This is the operational case for sourcing from suppliers that publish complete COAs and adhere to RUO standards.

Key Takeaway: The GHK-Cu literature remains largely pre-clinical, with stability handling and sourcing variability as the two operational risk factors most likely to compromise research reproducibility.

Shop Research-Grade GHK-cu Peptides

The Future of GHK-Cu and Copper Peptide Research

Emerging Combination Studies

Several investigative groups are examining GHK-Cu in combination with other signal peptides — notably matrikines such as Matrixyl, palmitoyl tripeptides, and acetyl hexapeptide-8 — in dermatological-research models. Whether combinations produce additive or synergistic effects across the gene-expression pathways modulated by GHK-Cu remains an open research question [12].

Next-Generation Signal Peptides

The broader signal-peptide field is expanding toward designed analogs, PEGylated derivatives, and copper-coordinating analogs of GHK that may modify pharmacokinetics or stability. Pickart and Margolina described early GHK-PEG work and its differential effects on cancer-cell versus fibroblast lines [13]. Whether any of these analogs displaces native GHK-Cu in the research literature will depend on the next decade of comparative data.

Key Takeaway: Combination studies with other signal peptides and chemical analogs of GHK represent the most active expansion frontiers in copper-peptide research. Translation into clinical applications remains an unresolved question.

Key Takeaways

– GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973.

– It functions as a multi-pathway signal peptide affecting fibroblast activity, copper trafficking, antioxidant signaling, and broad gene expression.

– The bulk of evidence is pre-clinical, concentrated in skin, wound-healing, and hair-follicle research.

– Research-grade GHK-Cu (≥99% HPLC, LC-MS confirmed) is distinct from cosmetic copper peptide formulations.

– Standard laboratory handling involves lyophilized −20 °C storage, reconstitution in sterile or bacteriostatic water, and aliquoting to limit freeze-thaw cycles.

– The compound is supplied strictly for research use only in the U.S. and is not FDA-approved for any human application.

Start Your Research Today

Every GHK-Cu vial we supply ships with full third-party Certificate of Analysis documentation — so your research begins with verified purity, not assumptions.

View All Research Peptides

Questions

Frequently Asked Questions About GHK-Cu

What is GHK-Cu peptide?

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, naturally present in human plasma at declining concentrations with age. In research, it functions as a signal peptide associated with collagen synthesis, fibroblast activation, antioxidant signaling, and broad gene modulation. It is supplied as a lyophilized powder for in-vitro and pre-clinical study, not for human use.

What is the chemical structure of GHK-Cu?

GHK-Cu consists of glycine, histidine, and lysine arranged in sequence (Gly-His-Lys), with a Cu²⁺ ion coordinated by the histidine imidazole, the N-terminal amine, and additional ligand contributions. The parent complex has a molecular weight near 403–404 g/mol, and the acetate-salt form near 462 g/mol. The deep cobalt-blue color confirms copper binding.

How does GHK-Cu work at the cellular level?

Investigators describe GHK-Cu as a signal peptide that engages multiple cellular pathways rather than a single receptor. Reported activities include fibroblast stimulation, controlled intracellular copper delivery, modulation of collagen and glycosaminoglycan synthesis, and broad changes in gene expression across stress-response and tissue-repair networks.

What is the mechanism of GHK-Cu in wound healing?

Pre-clinical wound-healing models report that GHK-Cu accelerates closure and improves tensile strength through a combination of fibroblast activation, angiogenic signaling, macrophage recruitment, and matrix-protein synthesis. The copper component supports enzymes including lysyl oxidase that are critical to collagen cross-linking.

What pathways does GHK-Cu modulate in skin cells?

Reported pathways include TGF-β signaling, antioxidant defense (superoxide dismutase, glutathione peroxidase), extracellular-matrix gene expression (collagen types I and III, decorin, perlecan), and inflammatory cytokine modulation. The Broad Institute gene-expression dataset documents changes across 4,192 human genes following GHK exposure.

How does GHK-Cu stimulate collagen and elastin?

In-vitro fibroblast studies indicate that GHK-Cu upregulates transcription of collagen and elastin genes and supplies copper as a cofactor for lysyl oxidase, the enzyme that cross-links these matrix proteins. The net effect in cell culture is increased deposition of structurally mature extracellular matrix.

What is GHK-Cu used for in research?

Common research applications include in-vitro fibroblast and keratinocyte studies, animal wound-healing models, hair-follicle and dermal-papilla research, post-procedure skin-recovery models, antioxidant-pathway investigations, and gene-expression profiling. All such work is conducted under research-use-only conditions.

How does GHK-Cu support skin regeneration in research models?

Pre-clinical and cosmetic-research data describe increased collagen and elastin synthesis, fibroblast proliferation, improved barrier-protein expression, and reduced markers of oxidative stress following GHK-Cu exposure. Human evidence remains limited to small panels and cosmetic-grade applications.

Can GHK-Cu be used in anti-wrinkle research?

Yes — GHK-Cu is one of the more frequently studied compounds in dermatological wrinkle-reduction research. Pre-clinical and small human-panel studies report improvements in wrinkle depth and skin density, attributed to upregulated collagen and elastin pathways.

What research exists on GHK-Cu and skin elasticity?

Multiple in-vitro fibroblast studies and a smaller number of clinical-cosmetic studies report improvements in skin elasticity associated with GHK-Cu exposure, linked to increased elastin synthesis and improved lysyl-oxidase-dependent cross-linking. The bulk of this evidence is pre-clinical.

How does GHK-Cu affect skin texture and firmness?

Reported effects on texture and firmness derive from upregulated extracellular matrix production, improved barrier protein expression, and increased fibroblast activity. These outcomes are described in cosmetic-research panels and pre-clinical models; therapeutic claims are not supported by FDA approval.

What is GHK-Cu's role in skin barrier repair?

In barrier-disruption models, GHK-Cu has been reported to support recovery of stratum-corneum lipids, tight-junction proteins, and ceramide synthesis. Investigators describe these effects as part of the compound's broader regenerative signaling profile.

What are GHK-Cu's effects on post-procedure skin in research?

Dermatology-research models simulating microneedling, laser, and chemical-peel injuries have reported shorter erythema duration and accelerated barrier recovery with GHK-Cu application. These findings are pre-clinical and cosmetic-research in nature, not validated therapeutic claims.

Can GHK-Cu support hair growth research?

GHK-Cu interacts with dermal papilla cells and has been examined in animal-model and ex-vivo follicle studies of androgenic alopecia. Reported outcomes include increased follicle size and prolonged anagen phase. Human evidence is limited and largely cosmetic.

What is GHK-Cu's effect on hair follicles in models?

In ex-vivo follicle culture and rodent models, GHK-Cu has been reported to stimulate dermal papilla proliferation, increase follicle diameter, and improve scalp vascularization. Mechanistic explanations include copper-dependent enzyme cofactor support and signaling-pathway activation.

How does GHK-Cu help in tissue repair and regeneration?

Pre-clinical work across skin, lung, liver, and bone models has reported tissue-repair activity, attributed to fibroblast restoration, antioxidant signaling, anti-inflammatory effects, and matrix-protein synthesis. The breadth of reported activity reflects the compound's broad gene-expression effects.

What is GHK-Cu's role in nerve and blood-vessel regrowth research?

Pre-clinical data points to upregulation of nerve growth factor and vascular endothelial growth factor in injury models, supporting interest in nerve regeneration and angiogenesis applications. This work remains early-stage and confined to animal and in-vitro studies.

How does GHK-Cu affect scars and wound healing?

Animal-model studies report improved tensile strength of healed wounds, reduced scar volume, and accelerated closure with GHK-Cu treatment. The mechanism is multifactorial: fibroblast activation, matrix-protein modulation, and inflammatory damping.

Is GHK-Cu safe for pre-clinical research?

GHK-Cu is generally well-tolerated in published in-vitro and animal-model work at standard research concentrations. Safety in human therapeutic contexts is not established, and the compound is not FDA-approved. Standard laboratory handling and personal protective equipment apply.

What is the typical GHK-Cu concentration used in studies?

Published in-vitro work commonly uses GHK-Cu in the range of 10 nM to 10 μM, with 1 μM as a frequently reported working concentration. Animal-model topical studies have used 0.05–0.2% (w/v) formulations. These figures describe research literature, not clinical guidance.

What solvent is used to dissolve GHK-Cu peptide powder?

GHK-Cu is water-soluble. Common research solvents include sterile water, bacteriostatic water (0.9% benzyl alcohol), and buffered saline at neutral pH. Stock solutions of 1–10 mg/mL are typical and are then diluted into culture medium for working concentrations.

How should GHK-Cu be stored for research purposes?

Lyophilized GHK-Cu is stored at −20 °C in sealed vials with desiccant, protected from light. Reconstituted solutions are typically kept at 2–8 °C and used within weeks, with long-term storage as frozen aliquots to minimize freeze-thaw degradation.

What is the shelf life of GHK-Cu peptide in lab settings?

Lyophilized GHK-Cu at −20 °C retains stability for 24 months or longer under typical research-storage conditions. Reconstituted aqueous solutions stored at 2–8 °C are generally used within 14–28 days for sensitive applications.

What analytical methods are used to test GHK-Cu purity?

Reversed-phase HPLC quantifies purity (the ≥99% threshold for research grade), and liquid-chromatography mass spectrometry (LC-MS) confirms identity by measuring molecular weight. Both analyses appear on a complete certificate of analysis.

What impurities should be checked in GHK-Cu peptide?

Common impurities to check include truncated peptide sequences (Gly-His or His-Lys fragments), residual coupling reagents and protecting groups, counterion residues, free (uncomplexed) GHK, and excess copper salts. A complete COA quantifies these as part of the impurity profile.

What is the difference between lab-grade GHK-Cu and cosmetic-grade copper peptide?

Lab-grade GHK-Cu is supplied as lyophilized powder with verified ≥99% HPLC purity, LC-MS identity confirmation, and a full COA — designated for research use only. Cosmetic-grade copper tripeptide-1 is a formulated topical product subject to cosmetic regulation, with no comparable analytical disclosure.

Where can I buy GHK-Cu peptide for research in the US?

Research-grade GHK-Cu is available from suppliers that publish complete certificates of analysis and operate under research-use-only labeling. Verification of HPLC and LC-MS documentation, batch-level transparency, and RUO designation are standard procurement criteria.

Which suppliers sell 99% purity GHK-Cu for research?

Research-grade suppliers providing 99% purity GHK-Cu typically share batch-level HPLC chromatograms, mass spectrometry traces, and COAs on request. Procurement teams generally evaluate suppliers on documentation depth, RUO compliance, and analytical transparency.

How do I choose a reputable GHK-Cu peptide supplier?

Look for ≥99% HPLC purity standards, full LC-MS identity confirmation, transparent certificate-of-analysis documentation, clear RUO labeling, and responsive technical support. Avoid suppliers that decline to share analytical documentation or that lack batch-level traceability.

What is the price range for GHK-Cu peptide for research?

Research-grade GHK-Cu pricing varies by vial size, purity certification depth, and supplier overhead. Procurement teams should evaluate cost per milligram against the completeness of analytical documentation rather than headline price alone.

What documentation should a GHK-Cu supplier provide?

A reputable supplier provides a complete COA with HPLC chromatogram, LC-MS identity data, batch and lot number, manufacture date, purity percentage, impurity profile, storage recommendations, and reconstitution guidance.

Can GHK-Cu be used in cell culture studies?

Yes — cell culture is one of the most common GHK-Cu research contexts. Investigators commonly use 10 nM to 10 μM concentrations in fibroblast, keratinocyte, and dermal-papilla cultures. Stock solutions are typically prepared in sterile water and diluted into culture medium.

What are the limitations of GHK-Cu peptide research?

Limitations include limited large-scale human clinical evidence, challenges in extrapolating in-vitro concentrations to in-vivo contexts, stability sensitivities (light, heat, alkaline pH), and variability in supplier purity. Most current evidence is pre-clinical.

How does GHK-Cu compare to other signal peptides?

GHK-Cu differs from other signal peptides (Matrixyl, acetyl hexapeptide-8, palmitoyl tripeptides) in its copper-coordinated mechanism and broad gene-expression effects. Comparative research on combinations is an active investigative area.

Why is GHK-Cu sold as research-only peptide?

GHK-Cu is sold as research-use-only because it has not been evaluated by the FDA for human therapeutic use. Research-grade material is intended for in-vitro studies, assay development, and pre-clinical animal-model work conducted in qualified laboratory settings.

How does GHK-Cu compare to copper tripeptide-1?

GHK-Cu and copper tripeptide-1 refer to the same Gly-His-Lys-Cu(II) molecule. The distinction is regulatory and contextual: "GHK-Cu" is used in scientific literature and research supply, while "copper tripeptide-1" is the INCI cosmetic-ingredient name.

Can GHK-Cu be combined with other peptides in research?

Combination research with other signal peptides (e.g., Matrixyl, palmitoyl tripeptides) is an active area in dermatological and regenerative-research literature. Whether combinations produce additive or synergistic effects remains an open question requiring further mechanistic study.

What is the current state of GHK-Cu clinical trials?

Large-scale human clinical trials on GHK-Cu remain limited. Most published evidence sits in in-vitro studies, animal models, and small cosmetic-research panels. The compound has not progressed through standard pharmaceutical-development trials for any therapeutic indication.

What analytical tests should be run on GHK-Cu before experiments?

Standard pre-experiment verification includes reviewing the supplier COA for HPLC purity (≥99%), LC-MS identity confirmation, and impurity profile. Some laboratories conduct in-house identity verification on receipt for sensitive applications.

Is GHK-Cu peptide for research available in the USA?

Research-grade GHK-Cu is supplied in the United States by RUO-compliant suppliers operating under research-reagent designation. Procurement is straightforward for academic and private research laboratories with appropriate institutional procurement procedures.

Still have questions?

Reach out to our team anytime

contact

References

Pickart L.
“The human tri-peptide GHK and tissue remodeling.”
Journal of Biomaterials Science, Polymer Edition.
2008;19(8):969–988.
Pickart L, Margolina A.
“Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.”
International Journal of Molecular Sciences.
2018;19(7):1987.
Pickart L, Vasquez-Soltero JM, Margolina A.
“GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.”
BioMed Research International.
2015;2015:648108.
Pickart L, Freedman JH, Loker WJ, et al.
“Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells.”
Nature.
1980;288(5792):715–717.
Beretta G, Artali R, Regazzoni L, et al.
“Glycyl-histidyl-lysine (GHK) is a quencher of α,β-4-hydroxy-trans-2-nonenal: comparison with carnosine.”
Chemical Research in Toxicology.
2007;20(9):1309–1314.
Pickart L, Margolina A.
“Skin regenerative and anti-cancer actions of copper peptides.”
Cosmetics.
2018;5(2):29.
Gruchlik A, Jurzak M, Chodurek E, Dzierżewicz Z.
“Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-α-dependent IL-6 secretion in normal human dermal fibroblasts.”
Acta Poloniae Pharmaceutica.
2012;69(6):1303–1306.
Pyo HK, Yoo HG, Won CH, et al.
“The effect of tripeptide-copper complex on human hair growth in vitro.”
Archives of Pharmacal Research.
2007;30(7):834–839.
Ahmed MR, Basha SH, Gopinath D, et al.
“Initial upregulation of growth factors and inflammatory mediators during nerve regeneration in the presence of cell adhesive peptide-incorporated collagen tubes.”
Journal of the Peripheral Nervous System.
2005;10(1):17–30.
Pickart L, Vasquez-Soltero JM, Margolina A.
“The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline.”
Brain Sciences.
2017;7(2):20.
U.S. Food and Drug Administration.
“Compounding and the FDA: Questions and Answers.”

https://www.fda.gov
Pickart L, Margolina A.
“The potential of GHK as an anti-aging peptide.”
AgingBiology.
2022.
Pickart L, Margolina A.
“Modulation of gene expression in human breast cancer MCF7 and prostate cancer PC3 cells by the human copper-binding peptide GHK-Cu.”
OBM Genetics.
2021;5(2):128.